Preclinical studies have shown that G-CSF derived from the hypoxic tumour cells is crucial for mobilization of myeloid-derived suppressor cells to visceral organs, thus increasing the metastatic potential of breast cancer cells [22]. Here, CSF3 is linked to breast carcinoma.